Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.

August 18, 2020 updated by: Haichao Li

Modified High-flow Nasal Cannula Oxygen in Patients Undergoing Bronchoscopy.

The purpose of this study is to determine whether the Modified High-flow nasal cannula is effective in the oxygen of the patients undergoing bronchoscopy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

812

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100020
        • Department of respiratory and critical care medicine,Beijing Chaoyang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria

  1. age more than 18 years old;
  2. need for bronchoscopy for diagnosis purpose.

Exclusion criteria

  1. peripheral arterial pulse oximetry was < 90%
  2. platelet count < 60 × 109/L;
  3. nasopharyngeal obstruction or blockage.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Modified High-flow nasal cannula therapy
Patients undergoing bronchoscopy are given Modified High-flow nasal cannula oxygen therapy all the time.
Modified High-flow nasal cannula
Active Comparator: Nasal cnnnula therapy
Patients undergoing bronchoscopy are given nasal cannula oxygen therapy all the time.
Conventional oxygen therap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the proportion of patients SpO2 < 90% during bronchoscopy
Time Frame: 1 hour
1 hour

Secondary Outcome Measures

Outcome Measure
Time Frame
the operation time
Time Frame: 1 hour
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

November 14, 2015

First Submitted That Met QC Criteria

November 14, 2015

First Posted (Estimate)

November 17, 2015

Study Record Updates

Last Update Posted (Actual)

August 19, 2020

Last Update Submitted That Met QC Criteria

August 18, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2015-ke-091

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchoscopy,Oxygen

Clinical Trials on Modified High-flow nasal cannula

3
Subscribe